Helius Medical Technologies Inc Class A (HSDT) Financials

$2.24

$-0.11 (-4.68%)

As on 04-Sep-2026 16:55EDT

Market cap

$135 Mln

Revenue (TTM)

$12 Mln

P/E Ratio

0

P/B Ratio

0.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	12.07	6.02	0.52	0.64	0.79	0.52
Cost of Revenue	0.54	0.50	0.58	0.58	0.46	0.30
Gross Profit	11.53	5.52	-0.06	0.06	0.32	0.22
Operating Expenses	35.73	26.64	13.84	12.49	15.84	18.37
Operating Profit (EBIT)	-24.20	-21.12	-13.90	-12.43	-15.52	-18.14
Other Income	--	--	--	--	--	--
Profit before Tax	-157.27	-40.89	-11.74	-8.85	-14.07	-18.13
Provision for Tax	--	--	--	-0.01	-1.51	-0.01
Profit after Tax (Net Income)	-157.27	-40.89	-11.74	-8.85	-14.07	-18.13
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-14.07	-18.13

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	165.65	300.91	1.06	2.35	8.15	11.26
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	4.21	--	0.32	3.46	7.15	0.19
Current Liabilities	2.16	3.02	2.16	1.88	1.99	2.65
Total Liabilities	178.21	303.93	3.54	7.69	17.29	14.10

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	147.31	272.77	0.12	0.39	0.59	1.51
Current Assets	28.75	31.16	3.42	7.30	16.70	12.59
Total Assets	178.21	303.93	3.54	7.69	17.29	14.10
Total Debt*	--	--	0.01	0.06	0.11	0.00
Net Current Assets	26.59	28.14	1.26	5.56	14.71	9.94

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-16.51	-11.04	-10.42	-14.31	-13.39
Cash Flow from Investing Activities	--	-426.53	-0.01	-0.03	-0.01	-0.06
Cash from Financing Activities	--	449.24	6.95	1.08	17.87	21.13
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-129.97	-1.85	-3,261.67	-4,657.89	-70,360.00	-181,320.00
Cash EPS ($)	--	-1.85	-3,245.00	-4,562.63	-69,085.00	-179,320.00
Adjusted Book Value ($)	--	13.65	294.17	1,236.84	40,755.00	112,560.00
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.75	-3,066.94	-5,482.11	-71,550.00	-133,880.00
Free Cash Flow per Share ($)	--	-2.78	-3,068.33	-5,497.37	-71,635.00	-134,420.00

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-27.08	-675.22	-165.92	-144.18	-238.25
ROE (%)	-67.42	-27.08	-688.88	-168.56	-145.02	-239.73
ROA (%)	-167.39	-26.60	-209.04	-70.86	-89.66	-175.62
EBIT Margin (%)	-223.98	-669.02	-2,665.96	-1,905.12	-1,875.35	-3,473.56
Net Margin (%)	-1,302.78	-679.57	-2,258.08	-1,374.22	-1,788.06	-3,473.56
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	3,992.20	10.57	-0.19	-0.18	0.51	-0.21
EBIT Growth (%)	-36.32	-190.38	-12.99	16.87	18.60	-28.32
Net Profit Growth (%)	-638.89	-248.24	-32.68	37.11	22.39	-28.32
EPS Growth (%)	95.52	1.00	0.30	0.93	0.61	--
Book Value Growth (%)	-13.38	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	0.01	-1.56	0.00	0.00	0.00	0.00
Price / Book Value	0.84	0.21	0.00	0.01	0.00	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.01	-1.43	0.08	0.42	1.00	0.62
Close Price ($)	1.65	2.89	502.73	6,029.25	11,508.75	194,625.00
High Price ($)	25.50	1,200.00	7,125.00	15,712.50	217,016.25	1,275,000.00
Low Price ($)	1.19	2.62	279.75	4,267.50	7,500.00	189,375.00
Market Cap ($ Cr)	135.43	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	0.01	0.02	0.01	0.00
Short term debt to equity ratio	--	--	0.01	0.02	0.01	0.00
Current Ratio	13.31	10.33	1.58	3.88	8.40	4.75
Quick Ratio	13.31	9.96	1.08	3.64	8.10	4.57
Interest Coverage	-116.54	-63.39	-815.47	-47.74	-17.70	-1,813.20

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	122.12	98.91	43.58	48.08
Asset Turnover	0.13	0.04	0.09	0.05	0.05	0.05
Receivable days	--	38.55	446.73	277.91	137.84	168.28
Inventory Days	--	807.93	485.74	327.66	420.08	530.10
Payable days	--	1,009.19	440.56	362.74	668.97	1,112.91
Cash Conversion Cycle	--	-162.71	491.91	242.82	-111.05	-414.53

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.